Opus Genetics, Inc. financial data

Symbol
IRD on Nasdaq
Location
Durham, NC
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 12 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 212% % -67%
Debt-to-equity 252% % 1076%
Return On Equity -452% % -151%
Return On Assets -115% % 13%
Operating Margin -272% % 52%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71,149,045 shares 56%
Common Stock, Shares, Outstanding 69,894,507 shares 121%
Entity Public Float $45,900,000 USD 19%
Common Stock, Value, Issued $7,000 USD 133%
Weighted Average Number of Shares Outstanding, Basic 62,221,901 shares 133%
Weighted Average Number of Shares Outstanding, Diluted 62,221,901 shares 133%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $14,196,000 USD 29%
General and Administrative Expense $21,983,000 USD 21%
Operating Income (Loss) $38,599,000 USD 38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $49,591,000 USD 14%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $49,591,000 USD 14%
Earnings Per Share, Basic -0.8 USD/shares 63%
Earnings Per Share, Diluted -0.8 USD/shares 63%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $45,091,000 USD 49%
Accounts Receivable, after Allowance for Credit Loss, Current $1,995,000 USD -44%
Other Assets, Current $86,000 USD 69%
Assets, Current $50,044,000 USD 37%
Property, Plant and Equipment, Net $199,000 USD -21%
Assets $50,243,000 USD 36%
Accounts Payable, Current $3,293,000 USD 4.6%
Employee-related Liabilities, Current $1,992,000 USD 35%
Accrued Liabilities, Current $4,488,000 USD -45%
Liabilities, Current $7,781,000 USD -31%
Liabilities $34,895,000 USD 209%
Retained Earnings (Accumulated Deficit) $188,589,000 USD -36%
Stockholders' Equity Attributable to Parent $15,348,000 USD 128%
Liabilities and Equity $50,243,000 USD 36%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $8,994,000 USD -57%
Net Cash Provided by (Used in) Financing Activities $20,465,000 USD 761%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 125,000,000 shares 0%
Common Stock, Shares, Issued 69,894,507 shares 121%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $45,091,000 USD 49%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $39,997,000 USD 13%
Deferred Tax Assets, Gross $40,027,000 USD 13%
Depreciation $23,000 USD 360%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $49,591,000 USD 14%
Property, Plant and Equipment, Gross $25,000 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $32,248,000 USD 59%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0.14%
Additional Paid in Capital $203,930,000 USD 40%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $30,000 USD 11%
Share-based Payment Arrangement, Expense $3,399,000 USD 1.1%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%